Carbohydrate sulfotransferases: a review of emerging diagnostic and prognostic applications.
cancer
carbohydrate sulfotransferases
connective tissue
inflammation
tumour markers
Journal
Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305
Informations de publication
Date de publication:
15 Oct 2023
15 Oct 2023
Historique:
received:
07
03
2023
accepted:
19
06
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
ppublish
Résumé
Carbohydrate sulfotransferases (CHST) catalyse the biosynthesis of proteoglycans that enable physical interactions and signalling between different neighbouring cells in physiological and pathological states. The study aim was to provide an overview of emerging diagnostic and prognostic applications of CHST. PubMed database search was conducted using the keywords "carbohydrate sulfotransferase" together with appropriate inclusion and exclusion criteria, whereby 41 publications were selected. Additionally, 40 records on CHST genetic and biochemical properties were hand-picked from UniProt, GeneCards, InterPro, and neXtProt databases. Carbohydrate sulfotransferases have been applied mainly in diagnostics of connective tissue disorders, cancer and inflammations. The lack of CHST activity was found in congenital connective tissue disorders while CHST overexpression was detected in different malignancies. Mutations of
Identifiants
pubmed: 37545696
doi: 10.11613/BM.2023.030503
pii: bm-33-3-030503
pmc: PMC10373059
doi:
Substances chimiques
Sulfotransferases
EC 2.8.2.-
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
030503Informations de copyright
Croatian Society of Medical Biochemistry and Laboratory Medicine.
Déclaration de conflit d'intérêts
Potential conflict of interest None declared.
Références
Clin Chem Lab Med. 2018 Jul 26;56(8):1328-1335
pubmed: 29648993
Am J Hum Genet. 2009 Dec;85(6):873-82
pubmed: 20004762
Chem Biol. 1999 Jan;6(1):R9-R22
pubmed: 9889154
Cell Death Discov. 2020 Sep 12;6(1):85
pubmed: 32983576
Methods Cell Biol. 2016;134:485-530
pubmed: 27312503
J Cell Physiol. 2006 Feb;206(2):283-94
pubmed: 15991249
Biochemistry. 2002 Nov 5;41(44):13117-26
pubmed: 12403612
Bioengineered. 2021 Dec;12(1):3934-3946
pubmed: 34288811
Dig Dis Sci. 2019 Aug;64(8):2158-2166
pubmed: 30815821
Thromb Res. 2018 Jan;161:43-51
pubmed: 29178990
ACS Chem Biol. 2012 Jan 20;7(1):31-43
pubmed: 22195988
J Cell Mol Med. 2021 May 16;:
pubmed: 33993645
Cancer Res. 2009 Dec 15;69(24):9202-10
pubmed: 19951989
Pharmacol Res. 2018 Sep;135:259-264
pubmed: 30118797
Clin Dysmorphol. 2014 Jan;23(1):12-15
pubmed: 24300290
J Pharm Biomed Anal. 2021 Oct 25;205:114339
pubmed: 34464868
Rheumatology (Oxford). 2015 Jul;54(7):1236-43
pubmed: 25573839
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10155-60
pubmed: 15215498
Front Immunol. 2020 Mar 24;11:512
pubmed: 32265939
Oncol Lett. 2019 Oct;18(4):4100-4105
pubmed: 31516610
Clin Genet. 2017 Jun;91(6):868-880
pubmed: 28229453
Front Oncol. 2020 Oct 15;10:554331
pubmed: 33178582
Cancer Med. 2023 Feb;12(4):4938-4950
pubmed: 36062845
Pathobiology. 2022;89(2):81-91
pubmed: 34788765
Clin Genet. 2016 Jul;90(1):90-5
pubmed: 26572954
Sci Rep. 2019 Jul 22;9(1):10542
pubmed: 31332239
FASEB J. 1997 Mar;11(4):206-16
pubmed: 9068609
Cells. 2022 Aug 04;11(15):
pubmed: 35954244
Annu Rev Biomed Eng. 2017 Jun 21;19:1-26
pubmed: 28226217
Biochim Biophys Acta. 2012 Sep;1820(9):1306-17
pubmed: 22343051
BMC Musculoskelet Disord. 2022 Aug 30;23(1):818
pubmed: 36042462
Tumour Biol. 2015 Nov;36(11):9023-30
pubmed: 26084610
Glycobiology. 2017 May 1;27(5):400-415
pubmed: 28025252
Int J Cancer. 2011 Jul 15;129(2):355-64
pubmed: 20878980
Nat Genet. 2000 Oct;26(2):237-41
pubmed: 11017086
Oncol Lett. 2017 Jun;13(6):4799-4805
pubmed: 28599481
Oncotarget. 2020 Jun 16;11(24):2327-2344
pubmed: 32595831
Int J Mol Sci. 2019 Jul 06;20(13):
pubmed: 31284594
Dig Dis Sci. 2016 Jul;61(7):1972-85
pubmed: 26993826
Anal Bioanal Chem. 2012 Jun;403(6):1491-500
pubmed: 22526635